Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_assertion type Assertion NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_head.
- NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_assertion description "[This validated assay is being applied to approximately 10, 000 lymph nodes in a prospective trial to define the sensitivity of Guanylyl cyclase C (GCC) qRT-PCR for staging patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_provenance.
- NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_assertion evidence source_evidence_literature NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_provenance.
- NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_assertion SIO_000772 16899600 NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_provenance.
- NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_assertion wasDerivedFrom lhgdn-20090331 NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_provenance.
- NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_assertion wasGeneratedBy ECO_0000203 NP218891.RARf436Gnmg7-876MbjHKhJm2NkLL3qoTGo6jPBs8u9qs130_provenance.